Major adverse cardiovascular events
Disease6 papers3 findings
- Human trial1
- Humans4
- In silico1
Upstream
2Retinal vascular morphology
no changein humans1
1 study
Retinal vascular morphology
no changein humans1
Retinal vascular morphology has no effect on major adverse cardiovascular events in humans.
“No retinal change metric was associated with major adverse cardiovascular events after false-discovery-rate correction.”
Humans5.7 years
Retinal vascular changes track mortality risk in humans · medRxiv · 2 Oct 2026 · Preprint
Oestradiol
no changein humans1HR 1.11
1 study
Oestradiol
no changein humans1HR 1.11
Oestradiol has no effect on major adverse cardiovascular events in humans (HR 1.11, 95% CI 0.73-1.67).
Humanshealthy older womenfemalesn = 5,535
Oestradiol levels do not predict heart events in older women · Maturitas · 28 Sep 2026
Associations
1Causal reinforcement learning framework
upin silico1
1 study
Causal reinforcement learning framework
upin silico1
causal reinforcement learning framework predicts major adverse cardiovascular events in silico (AUROCs of 0.720, 0.760, and 0.845).
In silicoevaluated across internal, emergency department, and MIMIC cohorts
From Image Interpretation to Clinical Reasoning: Upstream Physician-Context-Aware Multimodal Learning with Causal Reinforcement Learning · arXiv · 30 Sep 2026 · Preprint
Latest
19Association of pre-transplant electrocardiogram with long-term cardiovascular events in liver transplant recipients
Retinal vascular changes track mortality risk in humans
Increased retinal fractal dimension carried a mortality hazard ratio of 0.92 per standard deviation, whereas arteriolar widening carried a hazard…Increased retinal fractal dimension carried a mortality hazard ratio of 0.92 per standard deviation, whereas arteriolar widening carried a hazard ratio of 1.09.
Early ablation lowers cardiac risks in stroke patients with AF
At 36 months, early ablation yielded a 1.54-month gain in event-free survival and an 11.17% absolute risk reduction in major adverse cardiovascular…At 36 months, early ablation yielded a 1.54-month gain in event-free survival and an 11.17% absolute risk reduction in major adverse cardiovascular events versus medical therapy.